LOC653501 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.388480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.849800E-01
Normal-vs-Stage2
5.216600E-04
Normal-vs-Stage3
3.042100E-02
Normal-vs-Stage4
1.376250E-01
Stage1-vs-Stage2
1.262640E-01
Stage1-vs-Stage3
1.023780E-01
Stage1-vs-Stage4
2.775800E-01
Stage2-vs-Stage3
3.785000E-01
Stage2-vs-Stage4
7.381400E-01
Stage3-vs-Stage4
4.411000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.738020E-02
Normal-vs-AfricanAmerican
5.884400E-02
Normal-vs-Asian
3.155600E-02
Caucasian-vs-AfricanAmerican
7.955400E-01
Caucasian-vs-Asian
9.932600E-01
AfricanAmerican-vs-Asian
7.832400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.404600E-03
Normal-vs-Female
5.991900E-02
Male-vs-Female
2.150000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.238200E-01
Normal-vs-Age(41-60Yrs)
5.473900E-02
Normal-vs-Age(61-80Yrs)
5.478600E-03
Normal-vs-Age(81-100Yrs)
6.956600E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.672000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.182400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.483400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.168400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.651600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.136970E-01
Normal-vs-Daily Drinker
8.059000E-03
Normal-vs-Weekly Drinker
1.038820E-03
Normal-vs-Occasional Drinker
4.770000E-02
Normal-vs-Social Drinker
4.675200E-01
Non Drinker-vs-Daily Drinker
4.955600E-01
Non Drinker-vs-Weekly Drinker
5.458000E-01
Non Drinker-vs-Occasional Drinker
1.072020E-01
Non Drinker-vs-Social Drinker
2.363800E-02
Daily Drinker-vs-Weekly Drinker
8.747400E-01
Daily Drinker-vs-Occasional Drinker
3.502200E-01
Daily Drinker-vs-Social Drinker
5.688400E-02
Weekly Drinker-vs-Occasional Drinker
2.506000E-01
Weekly Drinker-vs-Social Drinker
4.200400E-02
Occasional Drinker-vs-Social Drinker
1.777220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.261030E-01
Normal-vs-Grade 2
6.356400E-02
Normal-vs-Grade 3
7.788000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.980300E-02
Grade 1-vs-Grade 3
3.223600E-02
Grade 1-vs-Grade 4
1.261030E-01
Grade 2-vs-Grade 3
9.232600E-01
Grade 2-vs-Grade 4
6.356400E-02
Grade 3-vs-Grade 4
7.788000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.940400E-03
Normal-vs-NonDiabetic
1.649750E-02
Diabetic-vs-NonDiabetic
1.576760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.362900E-03
Normal-vs-NoPancreatitis
1.249870E-02
Pancreatitis-vs-NoPancreatitis
3.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.117440E-01
Normal-vs-N1
3.044400E-04
N0-vs-N1
8.442200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.219000E-01
Normal-vs-TP53-NonMutant
3.332000E-01
TP53-Mutant-vs-TP53-NonMutant
3.93710000000658E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
